| 摘要 |
FIELD: medicine; pharmaceuticals.SUBSTANCE: invention provides an agent for treatment and prevention of neurodegenerative diseases and vascular dementia, comprising at least one lithium salt selected from lithium pyroglutamate, lithium thyrosinate, lithium argininate, lithium pyruvate, lithium lysinate, lithium malate, lithium alaninate, lithium lactate, lithium cysteinate, lithium tryptophanate, lithium aspartate, lithium benzoate, lithium adipate, lithium glycinate, lithium gluconate, lithium citrate, lithium nicotinate, lithium orotate, lithium salicylate and vitamin D in form of cholecalciferol or biologically active neurotrophic peptide selected from: glycine-glutamate-phenylalanine-serin-valine, tyrosine-glycine-glycine-phenylalanine-leucine, tyrosine-glycine-glycine-phenylalanine-methionine, cysteine-cysteine-arginine-glutamine-lysine, tryptophan-tryptophan-leucine-asparagine-serine-alanine-glycine-tyrosine.EFFECT: invention provides higher bioavailability for neurons, as well as safe treatment and prevention of using low doses of active substance.10 cl, 10 ex, 1 tbl |
